Global Genetic Engineering Market By Product type (Cell Line , Animal Genome, Plant Genome), By Technique (Artificial Selection, Cloning, Gene Splicing, Others)By End User (Pharmaceutical companies, Biotechnology Companies, Academics, Clinical Research Organizations)By Geography


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Genetic Engineering Market size is estimated to reach USD 10.09 billion by 2027 and is poised to grow at a CAGR of 15.55% during the forecast period 2021-2027. The alteration of genes in an organism or species to improve its skills is known as genetic engineering. Pharmaceutical and biotechnology firms, as well as clinical research institutions, utilise the technology. Gene therapy is the most extensively utilised therapeutic method for cancer and other infectious disorders in medicine. Genetic engineering Market alludes to the set of technologies that directly manipulate on an organism’s genes, change the genetic makeup of cells and add one or more new traits that are not found in that organism. At the core of all life is the thing that we call DNA. It is in charge of the plenitude of life on this Earth and the motivation behind why we are how we are. The hereditary make-up of any creature is characterized by DNA. In nature, the genetic nature never stays settled. Biotech and pharma sectors dominating the Genetic Engineering Market industry owing to several applications in drug discovery and therapeutics. With the increase in the use of CRISPR and ZFN, companies are capitalizing on innovative researches focusing on the development of editing techniques. For example, the introduction of an initiative called the Artemisinin Project is planning to use synthetic biology to help treat malaria. Key strategies implemented by industry players include mergers and acquisitions, strategic collaborations for R&D outsourcing or manufacturing activities are driving the market growth of genome editing. For instance, Thermo Fisher acquired Life technologies in 2014, to create unbeatable leadership in life sciences, research, specialty diagnostics and applied markets.

Genetic Engineering Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Market Dynamics

Increasing prevalence of cancer and other genetic disorders, growing preference for personalized medicine, Increase in R&D expenditure and growth of biotechnology and pharmaceutical industries, increase in private and public sector funding, rapid advancements in sequencing and genetic engineering technologies, applications in various drug discovery processes are some of the factors propelling the growth of the genetic engineering market. Moreover, Global genetic engineering market may be hindered by stringent government regulations for approval to gene mutation projects, ethical issues, unavailability of gene based therapeutics in the market and lack of awareness among people regarding the safety of genetic interventions.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2015-2020) and forecast (2021-2027)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Genetic Engineering Market Segmentation

By Type
  • Cell Line
  • Animal Genome
  • Plant Genome
by Technique
  • Artificial Selection
  • Cloning
  • Gene Splicing
  • Others
by End User
  • Pharmaceutical companies
  • Biotechnology Companies
  • Academics
  • Clinical Research Organizations
By Geography
North America
  • US
  • Canada
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe
  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific
Latin America
  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America
Middle East and Africa (MEA)
  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  • Thermo Fisher Scientific Inc. (US)
  • Merck KGaA (Germany)
  • Horizon Discovery Group Plc. (UK)
  • Transposagen Biopharmaceuticals Inc. (US)
  • New England Biolabs (U.S)
  • Genscript Biotech Corporation (US)
  • Lonza Group Ltd. (Switzerland)
  • Origene Technologies, Inc. (US)
  • Integrated DNA Technologies, Inc. (US)
  • Amgen Inc.(US)
  • Genentech, Inc. (US)
  • Sangamo Therapeutics, Inc. (US)